1. Du, Ruijuan, Li, Kai, Guo, Kelei, Han, Li, Bian, Hua. 2024. FSTL1: A double-edged sword in cancer development. In Gene, 906, 148263. doi:10.1016/j.gene.2024.148263. https://pubmed.ncbi.nlm.nih.gov/38346455/
2. Li, Xiaohe, Fang, Yinshan, Jiang, Dingyuan, Jiang, Dianhua, Ning, Wen. 2020. Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases. In Molecular therapy : the journal of the American Society of Gene Therapy, 29, 347-364. doi:10.1016/j.ymthe.2020.09.031. https://pubmed.ncbi.nlm.nih.gov/33007201/
3. Loh, Jia-Jian, Li, Tsz-Wai, Zhou, Lei, Tong, Man, Ma, Stephanie. 2021. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness. In Cancer research, 81, 5692-5705. doi:10.1158/0008-5472.CAN-20-4226. https://pubmed.ncbi.nlm.nih.gov/34551961/
4. Prakash, Stuti, Mattiotti, Andrea, Sylva, Marc, Postma, Alex V, van den Hoff, Maurice J B. 2019. Identifying pathogenic variants in the Follistatin-like 1 gene (FSTL1) in patients with skeletal and atrioventricular valve disorders. In Molecular genetics & genomic medicine, 7, e00567. doi:10.1002/mgg3.567. https://pubmed.ncbi.nlm.nih.gov/30722102/
5. Yao, Lizhong, Hou, Junyi, Wu, Xiongyan, Yan, Chao, Su, Liping. 2023. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. In Redox biology, 67, 102923. doi:10.1016/j.redox.2023.102923. https://pubmed.ncbi.nlm.nih.gov/37832398/
6. Chen, Yubing, Liao, Lijuan, Wang, Baoju, Wu, Zhan. 2024. Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning. In Frontiers in immunology, 15, 1332279. doi:10.3389/fimmu.2024.1332279. https://pubmed.ncbi.nlm.nih.gov/38390317/
7. Yu, Site, Cui, Xu, Zhou, Situo, Zhong, Yuhui, Zhang, Pihong. 2024. THOC7-AS1/OCT1/FSTL1 axis promotes EMT and serves as a therapeutic target in cutaneous squamous cell carcinoma. In Journal of translational medicine, 22, 347. doi:10.1186/s12967-024-05116-8. https://pubmed.ncbi.nlm.nih.gov/38605354/
8. Cheng, Shaoqiang, Huang, Yuanxi, Lou, Chun, Zhang, Yue, Zhang, Qingyuan. 2018. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation. In Cancer biology & therapy, 20, 328-337. doi:10.1080/15384047.2018.1529101. https://pubmed.ncbi.nlm.nih.gov/30336071/
智鼠故事 
